Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
Healthy aging research at UBC expanded with $24-million gift
On Mar. 7, 2018, a $24-million donation to the University of British Columbia’s (UBC) faculty of medicine will…
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
OHSU Doernbecher was the first in PNW to be ACS-verified as a Level 1 pediatric trauma center
On Feb. 22, 2018, OHSU Doernbecher Children’s Hospital was verified as a Level 1 Pediatric Trauma Center and…
The CPRIT awarded academic research and prevention grants totaling $73.5 million
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
Southwestern designated Hypertrophic Cardiomyopathy Center of Excellence
On Feb. 19, 2018, Southwestern Medical Center announced that it had been certified a Center of Excellence by…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
PNNL and OHSU created joint research co-laboratory to advance precision medicine
On Feb. 14, 2018, Pacific Northwest National Laboratory, (PNNL) and Oregon Health & Science University OHSU announced the…
FDA published guidance to industry known as the “red book”
On Jan. 31, 2018, the FDA published the first Red Book, the successor to 1949 “black book,” officially…
Biotechnology | CDC | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
Cleveland Clinic partnered with Martin Health System for first cardiovascular affiliation in Florida
On Jan. 26, 2018, Cleveland Clinic and Martin Health System announced an affiliation agreement to share best practices…
Celgene acquired Juno Therapeutics for $9 billion
On Jan. 22, 2018, Celgene and Juno Therapeutics announced the signing of a merger agreement in which Celgene…
The University of Michigan Cancer Center was renamed the Rogel Cancer Center
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
Native BioData Consortium was founded
In 2018, the Native BioData Consortium was founded as a 501(c)(3) nonprofit research institute led by Indigenous scientists…
Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
Costco co-founder Jeff Brotman and Dan Baty donated $50 million to create the Brotman Baty Institute for Precision Medicine
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
Ozempic (semaglutide) was approved in the U.S.
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
Scientists Created First Semi-Synthetic Organism that Stored and Retrieved Unnatural Information
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
The Calgary Cancer Centre broke ground
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
Paul G Allen Frontiers Group announced two new Allen Discovery Centers
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
$13.4 million to build next-gen MRI brain scanner at UC Berkeley
On Oct. 6, 2017, UC Berkeley researchers announced they had developed reimagined fMRI techniques and instruments to boost…
Michael Rosbash was awarded 2017 Nobel Prize in Physiology or Medicine
On Oct. 2, 2017, The Nobel Assembly announced that Michael Rosbash, a HHMI investigator, Jeffrey Hall of Brandeis…
Biotechnology | NIH | Oncology | Therapeutics
Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
Emory University’s Center for Selective C-H Functionalization was awarded a $20 million grant by the NSF to advance organic synthesis
On Oct. 2, 2017, Emory University’s Center for Selective C-H Functionalization (CCHF) was awarded a $20 million grant…
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Therapeutics
deCODE study revealed an ancient achilles heel in the human genome
On Sept. 20, 2017, resarchers at deCODE genetics use whole-genome data from 14,000 people from across the population…
FDA approval brought first gene therapy to the U.S.
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
Biotechnology | Disease | FDA | Neurology | Therapeutics
Adamas announced FDA approval of GOCOVRI as first and only medication fortreatment of Dyskinesia in Parkinson’s disease Patients
On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…